This external perspective matters because it exposes a truth that insiders have inadvertently normalised. Australia is trapped in a highly technical, self-referential, and fiercely procedural approach to HTA, without agreement on a philosophical foundation to guide decision-making. …
An interview that reminds us of the missing discussion in Australia
November 27, 2025 Latest NewsBioPharmaComment
Latest Video
Georgia Forrest
New Stories
-
Reform was justified because a committee prioritising clinical considerations was 'culturally' problematic
January 4, 2026 - - Latest News -
AdAlta and SHcell launch cancer collaboration to progress breakthrough CAR-T therapy
January 2, 2026 - - Australian Biotech -
Cabinet documents from the year that led to transformational changes
January 1, 2026 - - Latest News -
US pricing push gets real with Australia included in comparison list
December 22, 2025 - - Latest News -
Parsimony has unfortunately become an enduring test of the institution's legitimacy
December 20, 2025 - - Latest News -
PBAC delivers a broad range of outcomes in November, including for obesity
December 20, 2025 - - Latest News -
Takeda’s next-generation psoriasis therapy delivers landmark Phase 3 results
December 19, 2025 - - Latest News